Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 5
2015 5
2016 6
2017 4
2018 6
2019 2
2020 3
2021 5
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean magda marchetti (14 results)?
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Furlan A, Cea M, Pavan L, Galli M, Clissa C, Mangiacavalli S, Cafro AM, Girlanda S, Patriarca F, Minotto C, Bertoldero G, Barilà G, Pascarella A, Lico A, Paolini R, Rabassi N, Pescosta N, Porrazzo M, De Sabbata G, Pompa A, Bega G, Cavallin S, Guidotti F, Marcatti M, Rupolo M, Belotti A, Gherlinzoni F, Zambello R. Furlan A, et al. Among authors: marcatti m. Cancer Med. 2024 Apr;13(7):e7071. doi: 10.1002/cam4.7071. Cancer Med. 2024. PMID: 38558233 Free PMC article.
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients.
Piemontese S, Lupo Stanghellini MT, Sora F, Sica S, Peccatori J, Marcatti M, Metafuni E, Giammarco S, Greco R, Bruno A, Ciceri F, Bacigalupo A, Chiusolo P. Piemontese S, et al. Among authors: marcatti m. Bone Marrow Transplant. 2024 May;59(5):692-694. doi: 10.1038/s41409-024-02221-6. Epub 2024 Feb 14. Bone Marrow Transplant. 2024. PMID: 38355909 No abstract available.
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Autore F, Bramanti S, Lessi F, Innocenti I, Galli E, Rocchi S, Ribolla R, Derudas D, Oliva S, Stefanoni P, Marcatti M, Schenone A, La Nasa G, Crippa C, Zamagni E, Riva M, Mazza R, Mannina D, Sica S, Bacigalupo A, Laurenti L. Autore F, et al. Among authors: marcatti m. Haematologica. 2024 Mar 1;109(3):888-894. doi: 10.3324/haematol.2023.283719. Haematologica. 2024. PMID: 37646655 Free PMC article.
Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.
Liberatore C, Perini T, Passeri C, Ferla V, Fioritoni F, Girlando V, Iuliani O, Orsini A, Montanaro G, Farina F, Di Nicola A, Nitti R, Pulini S, Mastaglio S, Santarone S, Coppola M, Marktel S, Accorsi P, Ciceri F, Marcatti M, Di Ianni M. Liberatore C, et al. Among authors: marcatti m. Haematologica. 2023 Dec 1;108(12):3502-3505. doi: 10.3324/haematol.2023.283452. Haematologica. 2023. PMID: 37439346 Free PMC article. No abstract available.
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Ocio EM, Perrot A, Bories P, San-Miguel JF, Blau IW, Karlin L, Martinez-Lopez J, Wang SY, Bringhen S, Marcatti M, Mateos MV, Rodriguez-Otero P, Oliva S, Nogai A, Le Roux N, Dong L, Macé S, Gassiot M, Fitzmaurice T, Oprea C, Moreau P. Ocio EM, et al. Among authors: marcatti m. Leukemia. 2023 Jul;37(7):1521-1529. doi: 10.1038/s41375-023-01936-7. Epub 2023 Jun 14. Leukemia. 2023. PMID: 37316728 Free PMC article. Clinical Trial.
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases.
Giglio F, Xue E, Barone A, Lorentino F, Greco R, Ruggeri A, Zambelli M, Parisi C, Milani R, Clerici D, Piemontese S, Marktel S, Lazzari L, Marcatti M, Bernardi M, Corti C, Lupo-Stanghellini MT, Ciceri F, Peccatori J. Giglio F, et al. Among authors: marcatti m. Transplant Cell Ther. 2023 Aug;29(8):519.e1-519.e9. doi: 10.1016/j.jtct.2023.05.015. Epub 2023 May 25. Transplant Cell Ther. 2023. PMID: 37244644
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient.
Raccagni AR, Mileto D, Candela C, Bruzzesi E, Bracchitta F, Marcatti M, Curreli D, Ciceri F, Gismondo MR, Castagna A, Nozza S. Raccagni AR, et al. Among authors: marcatti m. J Med Virol. 2023 Jan;95(1):e28304. doi: 10.1002/jmv.28304. Epub 2022 Nov 19. J Med Virol. 2023. PMID: 36372449 No abstract available.
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Mangiacavalli S, Cartia CS, Galli M, Pezzatti S, Belotti A, Fazio F, Mina R, Marcatti M, Cafro A, Zambello R, Paris L, Barilà G, Olivares C, Pompa A, Mazza R, Farina F, Soldarini M, Benvenuti P, Pagani G, Palumbo M, Masoni V, Ferretti VV, Klersy C, Arcaini L, Petrucci MT. Mangiacavalli S, et al. Among authors: marcatti m. Haematologica. 2023 Mar 1;108(3):833-842. doi: 10.3324/haematol.2022.281342. Haematologica. 2023. PMID: 36200419 Free PMC article.
Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy.
Ferla V, Antonini E, Perini T, Farina F, Masottini S, Malato S, Marktel S, Lupo Stanghellini MT, Tresoldi C, Ciceri F, Marcatti M. Ferla V, et al. Among authors: marcatti m. Front Oncol. 2022 Aug 16;12:932852. doi: 10.3389/fonc.2022.932852. eCollection 2022. Front Oncol. 2022. PMID: 36052251 Free PMC article. Review.
49 results